Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade. (Q40361501)
Jump to navigation
Jump to search
scientific article published on October 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade. |
scientific article published on October 2005 |
Statements
Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade (English)
Yijiang Shi
Huajun Yan
Joseph Gera
Alan Lichtenstein
1 October 2005